Tests
A two-staged test with purified coagulation factors in the first stage, and a FXa-specific chromogenic substrate in the second stage. In the first stage, diluted sample plasma, which has been treated with Al(OH)3 to remove prothrombin, is mixed with a combined reagent (human serum, factor V, phospholipids and calcium). In the second stage, a subsample from the first stage is mixed with normal plasma, providing prothrombin and fibrinogen, and the clotting time is measured to deduce the amount of FVIII present.
For professionals
Indicators
This gene is involved in the splicing of mRNA.
Indicators
This gene is involved in RNA binding and pre-mRNA splicing.
Indicators
Vascular endothelial growth factor A (232 aa, ~27 kDa) is encoded by the human VEGFA gene. This protein plays a role in both cell proliferation and angiogenesis.
Tests
The determination of the amount of vascular endothelial growth factor C present in a sample.
For professionals
Tests
The determination of the amount of vascular epithelial growth factor present in a sample.
For professionals
Tests
The determination of the amount of vascular endothelial growth factor receptor 2 present in a sample.
For professionals
Tests
The determination of the amount of vascular endothelial growth factor receptor present in a sample.
For professionals
Tests
The determination of the amount of vascular epithelial growth factor present in a sample.
For professionals
Indicators
The term "vitamin K" refers to a group of chemically similar fat-soluble compounds called naphthoquinones: vitamin K1 (phytonadione) is found in plants and is the primary source of vitamin K for humans through dietary consumption, vitamin K2 compounds (menaquinones) are made by bacteria in the human gut, and vitamin K3 (menadione) is a water-soluble preparation available for adults only. Vitamin K is necessary for the liver to produce the coagulation factors II, VII, IX, and X, as well as the clotting factors protein C, protein S, and protein Z; vitamin K deficiency can result in deficiencies of these coagulation factors and excess bleeding. An injection of vitamin K is routinely given to newborn infants to prevent vitamin K deficiency bleeding, also known as hemorrhagic disease of the newborn. Vitamin K deficiency is rare in adults but may result from chronic malnutrition or an inability to absorb dietary vitamins.
Tests
The determination of the biological activity of von Willebrand coagulation factor cleaving protease, ADAMTS13, in a sample.
For professionals
Indicators
von Willebrand factor (2813 aa, ~309 kDa) is encoded by the human VWF gene. This protein is involved in platelet adhesion and blood coagulation.